For decades, cumbersome CPAP machines have been the primary way to help people with sleep apnea. A range of new options has recently come into focus.

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...

Researchers conducted an observational study using real‑world data to compare the effectiveness and safety of initiating three fixed‑dose long‑acting muscarinic antagonist (LAMA)-long‑acting beta‑2 ...

Chronic respiratory diseases such as asthma account for 4% of all deaths in South Africa and poverty is the main underlying driver of these diseases, say experts.

Distinct COPD phenotypes show differences in severity and mortality, with worse outcomes linked to income, race, rural living, and smoking.